Amneal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.

About AMRX

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. 

CEO
Chintu Patel
CEOChintu Patel
Employees
8,300
Employees8,300
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2002
Founded2002
Employees
8,300
Employees8,300

AMRX Key Statistics

Market cap
3.95B
Market cap3.95B
Price-Earnings ratio
885.21
Price-Earnings ratio885.21
Dividend yield
Dividend yield
Average volume
2.21M
Average volume2.21M
High today
$12.89
High today$12.89
Low today
$12.52
Low today$12.52
Open price
$12.76
Open price$12.76
Volume
2.76M
Volume2.76M
52 Week high
$12.89
52 Week high$12.89
52 Week low
$6.69
52 Week low$6.69

Stock Snapshot

The current Amneal Pharmaceuticals(AMRX) stock price is $12.61, with a market capitalization of 3.95B. The stock trades at a price-to-earnings (P/E) ratio of 885.21.

During the trading session on 2025-12-22, Amneal Pharmaceuticals(AMRX) shares reached a daily high of $12.89 and a low of $12.52. At a current price of $12.61, the stock is +0.7% higher than the low and still -2.2% under the high.

Trading volume for Amneal Pharmaceuticals(AMRX) stock has reached 2.76M, versus its average volume of 2.21M.

Over the past 52 weeks, Amneal Pharmaceuticals(AMRX) stock has traded between a high of $12.89 and a low of $6.69.

Over the past 52 weeks, Amneal Pharmaceuticals(AMRX) stock has traded between a high of $12.89 and a low of $6.69.

AMRX News

Simply Wall St 2d
Amneal Pharmaceuticals: Valuation Check After FDA Approval for New Epinephrine Injection

Amneal Pharmaceuticals (AMRX) just secured FDA approval for its 1 mg/mL epinephrine injection in single and multi dose vials, plugging into a critical hospital...

Amneal Pharmaceuticals: Valuation Check After FDA Approval for New Epinephrine Injection
Simply Wall St 4d
The Bull Case For Amneal Pharmaceuticals Could Change Following FDA Green Light For Hospital Epinephrine

In early December 2025, Amneal Pharmaceuticals announced FDA approval for its epinephrine injection USP 1 mg/mL in single- and multi-dose vials, a critical hosp...

The Bull Case For Amneal Pharmaceuticals Could Change Following FDA Green Light For Hospital Epinephrine
Simply Wall St 5d
Three Insider-Favored Growth Companies To Watch

As the U.S. stock market grapples with pressures on AI stocks and anticipates key economic data releases, investors are keenly observing how these factors influ...

Three Insider-Favored Growth Companies To Watch

People also own

Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.